Park Place Capital’s Bio-Techne TECH Stock Holding History

Park Place Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.1K	Hold	468	–	–	0.01%	522
2026 Q1	$24.5K	Hold	468	–	–	﹤0.01%	459
2025 Q4	$27.5K	Hold	468	–	–	0.01%	416
2025 Q3	$26K	Sell	468 -144	-24%	-$7.71K	0.01%	419
2025 Q2	$31.9K	Buy	612 +144	+31%	+$7.24K	0.01%	404
2025 Q1	$27.4K	Hold	468	–	–	0.01%	418
2024 Q4	$33.7K	Hold	468	–	–	0.01%	402
2024 Q3	$37.4K	Sell	468 -52	-10%	-$3.91K	0.01%	406
2024 Q2	$37.3K	Hold	520	–	–	0.01%	400
2024 Q1	$36.6K	Hold	520	–	–	0.01%	452
2023 Q4	$40.1K	Sell	520 -32	-6%	-$2.11K	0.02%	445
2023 Q3	$37.6K	Hold	552	–	–	0.01%	522
2023 Q2	$45.1K	Hold	552	–	–	0.01%	506
2023 Q1	$41K	Hold	552	–	–	0.01%	514
2022 Q4	$46K	Buy	+552	New	+$43.8K	0.01%	496

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Park Place Capital's TECH Position: Q2 2026 in Review

Park Place Capital held its Bio-Techne (TECH) position steady in Q2 2026 at 468 shares worth $33.1K. The position accounts for 0.01% of the portfolio, ranked #522.

Park Place Capital first reported a position in TECH in Q4 2022 and has held it in 15 quarters since. The position peaked at $46K in Q4 2022. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Park Place Capital held 468 shares of Bio-Techne worth $33.1K as of Q2 2026.
Park Place Capital left its Bio-Techne share count unchanged in Q2 2026.
Bio-Techne made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #522 holding.
Park Place Capital first reported a position in Bio-Techne in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Bio-Techne position peaked at $46K in Q4 2022.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.